Ignite Creation Date:
2024-05-06 @ 1:37 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01854372
Status:
WITHDRAWN
Last Update Posted:
2013-12-10
First Post:
2013-05-10
Brief Title:
Rituximab-HyperCVAD R-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine- R-MC in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement
Sponsor:
The University of Texas Health Science Center at San Antonio
Organization:
The University of Texas Health Science Center at San Antonio
Organization Data
Organization:
The University of Texas Health Science Center at San Antonio
Class:
OTHER
Study ID:
CTRC 11-53
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None